Becton Dickinson & Co. stock outperforms competitors on strong trading day
Becton Dickinson & Co. closed 3.20% below its 52-week high of $248.42, which the company achieved on March 28th.
Leadership Success Story Of Abhijeet Bhardwaj's Revenue Re-Architecture Project At Becton Dickinson
Abhijeet Bhardwaj's commitment to technical excellence and innovation continues to drive successful outcomes in large-scale ...
Becton Dickinson EVP sells $120,000 in company stock
In a recent transaction, Shan David, Executive Vice President and Chief ISC Officer at Becton Dickinson & Co (NYSE:BDX), sold ...
Becton Dickinson, Biosero announce framework collaboration agreement
Becton, Dickinson and Company and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, announced a ...
Masimo taps Becton Dickinson executive Katie Szyman as CEO
(This Jan. 21 story has been corrected to fix the share price gain to 57% from 45% in paragraph 6) (Reuters) - Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device ...
Becton Dickinson price target lowered to $278 from $312 at Barclays
Barclays analyst Matt Miksic lowered the firm’s price target on Becton Dickinson (BDX) to $278 from $312 and keeps an Overweight rating on the ...
Jefferson nurses reported a defective IV needle and contributed to a national recall. Jefferson wants more staffers to report potential problems.
Paoletti, a charge nurse at Jefferson Torresdale Hospital, reported the problem internally, through the health system’s Great ...
Assembly Mag1d
Becton Dickinson Boosts U.S. Manufacturing of Critical Medical Devices
Becton, Dickinson and Co. (BD) is investing in its U.S. manufacturing network to add capacity for critical medical devices, ...
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors
Shares of Becton Dickinson & Co. BDX shed 1.02% to $237.92 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.61% to 6,086 ...
Is Becton, Dickinson and Company (BDX) an Undervalued Stock?
Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” fourth quarter 2024 investor letter. A copy ...
Becton, Dickinson and Company's (NYSE:BDX) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?
Becton Dickinson's (NYSE:BDX) stock is up by 4.3% over the past month. As most would know, long-term fundamentals ...
TMCnet20h
BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
The new versions of BD flow cytometer instrument software compatible with Biosero automation software for the BD FACSymphony A1™ Cell Analyzer, BD FACSymphony™ A5 SE Cell Anal ...